22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Cowen on 22nd Century Group (XXII): 'GVB provides an attractive platform for XXII to build on its existing capabilities in cannabis'
August 9, 2022 4:43 PM EDTCowen analyst Vivien Azer reiterated an Outperform rating and $5.00 price target on 22nd Century Group (NASDAQ: XXII).
The analyst comments "GVB Acquisition Scales Cannabis Business. Revenue from hemp/cannabis related products in the 2Q22 was $4.5 mm, compared to $0 in the year ago... More
22nd Century Group (XXII) Reports In-Line Q2 EPS
August 9, 2022 6:09 AM EDT22nd Century Group (NASDAQ: XXII) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $11.53 million.
For earnings history and earnings-related data on 22nd Century Group (XXII) click here.
... More